Break Up Big Medicine Act: A Deep Dive into the Bipartisan Bill

A new bipartisan bill, the “Break Up Big Medicine Act,” introduced on February 10, 2026, aims to address the increasing consolidation within the healthcare industry. Senators Elizabeth Warren (D-MA) and Josh Hawley (R-MO) sponsored the legislation, which seeks to prohibit common ownership of health plans and providers, as well as restrict ownership by pharmaceutical and medical device companies. This article provides a detailed overview of the bill, its potential impact and enforcement mechanisms.

Understanding the Core of the Bill

The “Break Up Big Medicine Act” targets the ownership structures driving vertical integration in healthcare. Specifically, it would make it unlawful for any entity to directly or indirectly own, control, or operate both a healthcare provider or management services organization and an insurance company or pharmacy benefit manager (PBM). The bill’s text, however, contains ambiguities regarding the definition of “insurance company,” potentially encompassing all common ownership of providers and health plans, including health systems operating subsidiary health plans.

Potential Impacts and Concerns

If enacted, the bill could significantly disrupt the operations of integrated healthcare systems that have long-standing commitments to integrated care settings and operate their own health plans. The legislation mandates divestment within one year of enactment, forcing affected entities to choose between owning either a provider/management services organization or an insurance company/PBM. Failure to comply would result in penalties, including profit disgorgement and forced asset sales.

Enforcement Mechanisms

The bill outlines multiple avenues for enforcement:

• Federal Trade Commission (FTC) and Department of Justice (DOJ): Both agencies would share enforcement jurisdiction.
• Department of Health and Human Services (HHS) and State Attorneys General: The HHS Office of Inspector General and state attorneys general would have the authority to bring civil actions in U.S. District Court.
• Private Right of Action: Private citizens could allege harm resulting from noncompliance and seek treble damages, attorney’s fees, and equitable relief.

Current Status and Future Outlook

As of March 9, 2026, the bill has been referred to the Judiciary Committee. Continued monitoring of its progress is recommended.

Disclaimer: The content of this article is intended for general informational purposes only and does not constitute legal advice. Specialist advice should be sought regarding specific circumstances.